These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
154 related articles for article (PubMed ID: 23236597)
1. [Comparison of CT- and MRI-based clinical target volumes for 3-dimensional conformal external-beam radiotherapy of prostate cancer]. Szabó Z; Agoston P; Major T; Horváth K; Jederán E; Polgár C Magy Onkol; 2012 Dec; 56(4):267-73. PubMed ID: 23236597 [TBL] [Abstract][Full Text] [Related]
2. [Changes in target volumes definition by using MRI for prostate bed radiotherapy planning--preliminary results]. Sefrová J; Paluska ; Odrázka K; Belobradek Z; Hoffmann P; Prosvic P; Brod'ák M; Louda M; Macingová Z; Vosmik M Klin Onkol; 2010; 23(4):256-63. PubMed ID: 20806824 [TBL] [Abstract][Full Text] [Related]
3. Magnetic resonance imaging for prostate bed radiotherapy planning: An inter- and intra-observer variability study. Barkati M; Simard D; Taussky D; Delouya G J Med Imaging Radiat Oncol; 2016 Apr; 60(2):255-9. PubMed ID: 26568515 [TBL] [Abstract][Full Text] [Related]
4. Definition of the prostate in CT and MRI: a multi-observer study. Rasch C; Barillot I; Remeijer P; Touw A; van Herk M; Lebesque JV Int J Radiat Oncol Biol Phys; 1999 Jan; 43(1):57-66. PubMed ID: 9989514 [TBL] [Abstract][Full Text] [Related]
5. Automatic Substitute Computed Tomography Generation and Contouring for Magnetic Resonance Imaging (MRI)-Alone External Beam Radiation Therapy From Standard MRI Sequences. Dowling JA; Sun J; Pichler P; Rivest-Hénault D; Ghose S; Richardson H; Wratten C; Martin J; Arm J; Best L; Chandra SS; Fripp J; Menk FW; Greer PB Int J Radiat Oncol Biol Phys; 2015 Dec; 93(5):1144-53. PubMed ID: 26581150 [TBL] [Abstract][Full Text] [Related]
6. Comparison of MRI with CT for the radiotherapy planning of prostate cancer: a feasibility study. Khoo VS; Padhani AR; Tanner SF; Finnigan DJ; Leach MO; Dearnaley DP Br J Radiol; 1999 Jun; 72(858):590-7. PubMed ID: 10560342 [TBL] [Abstract][Full Text] [Related]
7. Anatomic variations due to radical prostatectomy. Impact on target volume definition and dose-volume parameters of rectum and bladder. Sanguineti G; Castellone P; Foppiano F; Franzone P; Marcenaro M; Tognoni P; Bolognesi A; Ceresoli GL; Fiorino C Strahlenther Onkol; 2004 Sep; 180(9):563-72. PubMed ID: 15378187 [TBL] [Abstract][Full Text] [Related]
8. Magnetic resonance imaging in the radiation treatment planning of localized prostate cancer using intra-prostatic fiducial markers for computed tomography co-registration. Parker CC; Damyanovich A; Haycocks T; Haider M; Bayley A; Catton CN Radiother Oncol; 2003 Feb; 66(2):217-24. PubMed ID: 12648794 [TBL] [Abstract][Full Text] [Related]
9. Feasibility of CBCT-based target and normal structure delineation in prostate cancer radiotherapy: multi-observer and image multi-modality study. Lütgendorf-Caucig C; Fotina I; Stock M; Pötter R; Goldner G; Georg D Radiother Oncol; 2011 Feb; 98(2):154-61. PubMed ID: 21176984 [TBL] [Abstract][Full Text] [Related]
10. Prostate volumes and organ movement defined by serial computerized tomographic scans during three-dimensional conformal radiotherapy. Roach M; Faillace-Akazawa P; Malfatti C Radiat Oncol Investig; 1997; 5(4):187-94. PubMed ID: 9327498 [TBL] [Abstract][Full Text] [Related]
11. The effect of interobserver variability on transrectal ultrasonography-based postimplant dosimetry. Xue J; Waterman F; Handler J; Gressen E Brachytherapy; 2006; 5(3):174-82. PubMed ID: 16864069 [TBL] [Abstract][Full Text] [Related]
12. Converting from CT- to MRI-only-based target definition in radiotherapy of localized prostate cancer: A comparison between two modalities. Seppälä T; Visapää H; Collan J; Kapanen M; Beule A; Kouri M; Tenhunen M; Saarilahti K Strahlenther Onkol; 2015 Nov; 191(11):862-8. PubMed ID: 26168782 [TBL] [Abstract][Full Text] [Related]
13. MRI simulation: effect of gradient distortions on three-dimensional prostate cancer plans. Mah D; Steckner M; Hanlon A; Freedman G; Milestone B; Mitra R; Shukla H; Movsas B; Horwitz E; Väisänen PP; Hanks GE Int J Radiat Oncol Biol Phys; 2002 Jul; 53(3):757-65. PubMed ID: 12062622 [TBL] [Abstract][Full Text] [Related]
14. Comparing adaptation strategies in MRI-guided online adaptive radiotherapy for prostate cancer: Implications for treatment margins. Dassen MG; Janssen T; Kusters M; Pos F; Kerkmeijer LGW; van der Heide UA; van der Bijl E Radiother Oncol; 2023 Sep; 186():109761. PubMed ID: 37348607 [TBL] [Abstract][Full Text] [Related]
15. The contribution of integrated PET/CT to the evolving definition of treatment volumes in radiation treatment planning in lung cancer. Ashamalla H; Rafla S; Parikh K; Mokhtar B; Goswami G; Kambam S; Abdel-Dayem H; Guirguis A; Ross P; Evola A Int J Radiat Oncol Biol Phys; 2005 Nov; 63(4):1016-23. PubMed ID: 15979817 [TBL] [Abstract][Full Text] [Related]
16. Do differences in target volume definition in prostate cancer lead to clinically relevant differences in normal tissue toxicity? Livsey JE; Wylie JP; Swindell R; Khoo VS; Cowan RA; Logue JP Int J Radiat Oncol Biol Phys; 2004 Nov; 60(4):1076-81. PubMed ID: 15519777 [TBL] [Abstract][Full Text] [Related]
17. [Patient positioning using in-room kV CT for image-guided radiotherapy (IGRT) of prostate cancer]. Kliton J; Agoston P; Major T; Polgár C Magy Onkol; 2012 Sep; 56(3):193-8. PubMed ID: 23008828 [TBL] [Abstract][Full Text] [Related]
18. Intra- and inter-observer variability in contouring prostate and seminal vesicles: implications for conformal treatment planning. Fiorino C; Reni M; Bolognesi A; Cattaneo GM; Calandrino R Radiother Oncol; 1998 Jun; 47(3):285-92. PubMed ID: 9681892 [TBL] [Abstract][Full Text] [Related]
19. Comparative treatment planning on localized prostate carcinoma conformal photon- versus proton-based radiotherapy. Mock U; Bogner J; Georg D; Auberger T; Pötter R Strahlenther Onkol; 2005 Jul; 181(7):448-55. PubMed ID: 15995838 [TBL] [Abstract][Full Text] [Related]
20. Interobserver delineation variation using CT versus combined CT + MRI in intensity-modulated radiotherapy for prostate cancer. Villeirs GM; Van Vaerenbergh K; Vakaet L; Bral S; Claus F; De Neve WJ; Verstraete KL; De Meerleer GO Strahlenther Onkol; 2005 Jul; 181(7):424-30. PubMed ID: 15995835 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]